These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?

By GINA KOLATA from NYT Health https://ift.tt/2DOZiTD
via IFTTT
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them? - By GINA KOLATA - at Health - Keyword: Repatha (Drug), Drugs (Pharmaceuticals), Health Insurance and Managed Care, Cholesterol - From The New York Times - Published at October 2, 2018 at 07:00AM